Kadcyla 100mg Injection

Ado-trastuzumab emtansine (100mg) Primary uses of : Breast cancer
*
₹ 1,55,585.00 incl tax
Composition Ado-trastuzumab emtansine (100mg)
Potentially Unsafe With Lactation
Side Effect Common Tiredness, Nausea, Musculoskeletal (bone, muscle or joint) pain, Bleeding, Low blood platelets, Headache, Liver disorder, Constipation, Nose bleed.
How to works How Kadcyla Injection works Kadcyla 100mg Injection is an anti-cancer medicine. It binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body's immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.